BCAX compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name

BCAXBicara Therapeutics Inc.

Mkt capRevenueRevenue

ASNDAscendis Pharma A/S

Mkt capRevenueRevenue

Compare

BCAXBicara Therapeutics Inc.

ASNDAscendis Pharma A/S

Price

Mkt cap

Revenue

Supply-chain overlap

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

direct ties · both sidesSources ›

direct ties · both sides

Only BCAX 2

MSDMSD International GmbH and MSD International Business GmbHsupplier

—Bioconunlistedsupplier

Shared 0

No shared counterparties.

Only ASND 3

NVONovo Nordisk A/Scustomer

—Teijinunlistedcustomer

—VISEN Pharmaceuticalsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

BCAXBicara Therapeutics Inc.

7.91· pre 7.88· delayed

Mkt cap$620.2M

ASNDAscendis Pharma A/S

250.44· pre 250.44· delayed

Pre-marketNov 3 '26delayed

Mkt cap$15.6B

Compare

Pre-marketNov 3 '26delayed

BCAXBicara Therapeutics Inc.

ASNDAscendis Pharma A/S

7.91pre 7.88delayed

Price

250.44pre 250.44delayed

$620.2M

Mkt cap

$15.6B

BCAX7.91vsASND250.44Pre-marketNov 3 '26delayed